Upgrade to SI Premium - Free Trial

Merck (MRK): Raising PT To $72 - UBS

July 31, 2017 8:12 AM
UBS analyst, Marc Goodman, reiterated his Buy rating on shares of Merck (NYSE: MRK) and raised his price target to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles